Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Shares of the biotech Neumora Therapeutics began the first trading day of 2025 with a loss of more than 80% after the company ...

Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing impurities.

Jan 2 (Reuters) - Neumora Therapeutics' (NMRA.O), opens new tab shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and ...

New York, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Overview: The Antidepressant Drugs Market size is expected to reach USD 20.1 billion by 2024 and is further anticipated to reach USD 26.9 billion by ...

Antidepressants known as selective serotonin reuptake inhibitors, or SSRIs have been the first line of treatment for mood ...

During pregnancy, a health care provider will generally need to manage two different clinical scenarios: 1) starting medications, either for a woman with new-onset depression or for a woman ...